DANIPHARM A/S: Financial statements 2021
CVR: 12335040
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
DANIPHARM A/S (CVR 12335040) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 29,394,577 and a net result of DKK 2,944,039 compared with DKK 5,767,443 the year before. That is a decrease of 7.1% compared with the year before. Equity in the 2021 report amounted to DKK 29,868,508. The solvency ratio was 40.8%. The company had 25 employees in the financial year.
- Gross Profit
- DKK 29,394,577
- Profit/Loss
- DKK 2,944,039
- Equity
- DKK 29,868,508
- Total Assets
- DKK 73,177,565
- Employees
- 25
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 29.4 mio. | 2.9 mio. | 29.9 mio. | 25 |
| 2020 | 91.6 mio. | 31.6 mio. | 5.8 mio. | 26.9 mio. | 22 |
| 2019 | - | 42.9 mio. | 16.3 mio. | 21.2 mio. | 21 |
| 2018 | - | 35.7 mio. | 10.2 mio. | 24.8 mio. | 22 |
| 2017 | 93.6 mio. | 37 mio. | 11.3 mio. | 50.6 mio. | 26 |
Official annual report
Find more companies like DANIPHARM A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout DANIPHARM A/S
DANIPHARM A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1988. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Niels Ulrik Heine (chair), Helle Rørvig and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 37,586,751 and a net result of DKK 13,717,304 compared with DKK 5,113,647 the year before. Equity in the 2025 report amounted to DKK 60,280,949.